CoChat

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis

Open access
Shang, Bin, Liu, Yao, Jiang, Shu-juan, Liu, Yi · 2015 · Scientific Reports

Abstract

The prognostic value of FoxP3(+) regulatory T cells (Tregs) in cancer remains controversial. We did a meta-analysis to assess the prognostic effect of FoxP3(+) Treg across different types of cancer and to investigate factors associated with variations in this effect. PubMed, Embase, Cochrane CENTRAL, and Scopus were searched to identify eligible studies. In total, we analyzed 76 articles encompassing 17 types of cancer, and including 15,512 cancer cases. The overall pooled analysis including all types of cancer suggested FoxP3(+)Tregs had a significant negative effect on overall survival (OS) (OR 1.46, P < 0.001), but the prognostic effect varied greatly according to tumor site. High FoxP3(+) Tregs infiltration was significantly associated with shorter OS in the majority of solid tumors studied, including cervical, renal, melanomas, and breast cancers, et al; whereas, FoxP3(+) Tregs were associated with improved survival in colorectal, head and neck, and oesophageal cancers. The stratified analysis suggested the molecular subtype and tumor stage significantly influenced the prognostic value of FoxP3(+) Tregs in certain types of cancer. In conclusion, our meta-analysis suggests that the prognostic role of FoxP3(+) Tregs was highly influenced by tumor site, and was also correlated with the molecular subtype and tumor stage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep15179

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow diagram of search strategy and study selection.
Figure 1 Flow diagram of search strategy and study selection.CC BY · PubMed Central
Figure 2 Summary risk estimates of overall survival (OS) by cancer sites.
Figure 2 Summary risk estimates of overall survival (OS) by cancer sites.CC BY · PubMed Central
Figure 3 Summary risk estimates of disease-free survival (DFS) by cancer sites.
Figure 3 Summary risk estimates of disease-free survival (DFS) by cancer sites.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 985

Metadata

Authors
Shang, B., Liu, Y., Jiang, S.-J., & Liu, Y.
Affiliations
Shandong University (CN)
Corresponding author
Liu, Yi
Venue
Scientific Reports
Published
2015-10-14
Volume
5
Issue
1
Pages
15179-15179
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2419439766
Cited by
985
References
51
Citations by year
2026: 51 · 2025: 84 · 2024: 101 · 2023: 94 · 2022: 148 · 2021: 139 · 2020: 118 · 2019: 91 · 2018: 87 · 2017: 47 · 2016: 24 · 2015: 1
FWCI
4.99
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (81301790)
  • Natural Science Foundation of Shandong Province
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
Foxp3+ regulatory T cells, tumor-infiltrating lymphocytes, prognostic factors, overall survival, cancer, tumor location, molecular subtypes, tumor stage, solid tumors, cervical cancer, kidney cancer, melanoma, breast cancer, colorectal cancer, head and neck cancer, esophageal cancer
MeSH terms
Female, Humans, Male, Neoplasms, Prognosis, Sensitivity and Specificity, Biomarkers, Tumor, Reproducibility of Results, Prevalence, Survival Rate, Risk Assessment, T-Lymphocytes, Regulatory, Forkhead Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.